Participant characteristics
| Characteristic | N=404 |
| Sex, n (%) | |
| Male | 142 (35) |
| Female | 262 (65) |
| Age, mean (SD) | 44.1 (12.0) |
| Employment status | |
| Full time | 227 (56) |
| Part time | 75 (19) |
| Homemaker/housewife | 21 (5) |
| Student | 10 (2) |
| Unemployed | 30 (7) |
| Retired | 35 (9) |
| Disabled | 12 (3) |
| Other | 2 (0) |
| Education, n (%) | |
| No formal qualifications | 1 (0) |
| Primary school or secondary education | 38 (9) |
| College or some university | 43 (11) |
| Completed vocational or professional certification | 83 (21) |
| Completed university degree | 148 (37) |
| Completed doctorate, post-doctorate, or equivalent | 88 (22) |
| Other | 3 (1) |
| Overall health, n (%) | |
| Excellent | 20 (5) |
| Very good | 96 (24) |
| Good | 161 (40) |
| Fair | 98 (24) |
| Poor | 29 (7) |
| Prior experience with self-injectables (any)* | |
| Yes | 129 (32) |
| No | 275 (68) |
| Self-rated eczema severity, n (%) | |
| Very mild | 19 (5) |
| Mild | 116 (29) |
| Moderate | 212 (52) |
| Severe | 45 (11) |
| Very severe | 12 (3) |
| POEM overall score, n (%) | |
| Clear or almost clear (0–2) | 32 (8) |
| Mild eczema (3–7) | 121 (30) |
| Moderate eczema (8–16) | 192 (48) |
| Severe eczema (17–24) | 47 (12) |
| Very severe eczema (25–28) | 12 (3) |
| Class of AD medication currently used, n (%)† | |
| Topical corticosteroids | 265 (66) |
| Topical calcineurin inhibitors | 32 (8) |
| Phototherapy/UV treatment | 20 (5) |
| Systemic immunosuppressant therapies | 109 (27) |
| Biologics | 72 (18) |
| Most frequently used current AD medications, n (%)† | |
| Betamethasone | 119 (29) |
| Hydrocortisone | 97 (24) |
| Prednisone | 61 (15) |
| Clobetasol propionate | 46 (11) |
*Participants were not asked whether their prior use of self-injectables was for AD.
†Not mutually exclusive.
AD, atopic dermatitis; POEM, Patient Oriented Eczema Measure; UV, ultraviolet.